Patients & Disease Areas Focus
Ongoing Trials
- Therapeutic area:
- Oncology; Oncodermatology
- Status:
- Completed
- Study ID:
- ASN-002-001 (NCT02550678)
Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor
- Therapeutic area:
- Oncology; Oncodermatology
- Status:
- Recruiting
- Study ID:
- ASN-002-003 (NCT04416516)
For more information on our trials, visit www.clinicaltrials.gov